secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2024-07-29T23:59:59+00:00
Accession:  0001823239-24-000091
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai CEO Trey Martin appointed to Board of Directors, effective July 31, 2024
--------------------------------------------------------------------------------

- CEO William 'Trey' Martin III appointed as Class III director, effective July 31, 2024.
- Appointment fills Board vacancy created by Anat Ashkenazi's previously-reported resignation.
- Martin receives no additional compensation for Board service; retains existing CEO compensation.
- Term runs until 2026 annual meeting; Martin is one of two executives on the Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323924000091/0001823239-24-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323924000091/mrvi-20240723.htm
  HTML page:      https://secwatch.observer/filing/0001823239-24-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer